Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance. - Test2 - elhamkhani - TriplyDB

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.

http://www.wikidata.org/entity/Q33903965

about

Novel Molecular Markers for Breast Cancer Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer Meroxest improves the prognosis of immunocompetent C57BL/6 mice with allografts of E0771 mouse breast tumor cells.Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer Predictors of recurrence in breast cancer subtypes with negative lymph node in a Chinese population.Cyclin D1, Id1 and EMT in breast cancer.Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta)Ki-67 labeling in canine perianal glands neoplasms: a novel approach for immunohistological diagnostic and prognostic.β-Catenin is required for Ron receptor-induced mammary tumorigenesis Low expression of TBX4 predicts poor prognosis in patients with stage II pancreatic ductal adenocarcinoma.DMP1β, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancer Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction The T box transcription factor TBX2 promotes epithelial-mesenchymal transition and invasion of normal and malignant breast epithelial cells.Estrogen receptor, progesterone receptor, and Her 2 Neu positivity and its association with tumour characteristics and menopausal status in a breast cancer cohort from northern Pakistan.Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells.Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer.Long non-coding RNAs as prognostic markers in human breast cancer.Aberrant expression of cyclin D1 in cancer.Clinical applications of mouse models for breast cancer engaging HER2/neu.Human Vγ2Vδ2 T cells limit breast cancer growth by modulating cell survival-, apoptosis-related molecules and microenvironment in tumors.Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.Novel plasma telomerase detection method to improve cancer diagnostic assessment.TBX2 expression is associated with platinum-sensitivity of ovarian serous carcinoma.Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer.Second-harmonic patterned polarization-analyzed reflection confocal microscopy of stromal collagen in benign and malignant breast tissues

P2860

Q26753160-67768C58-3825-4673-B24D-31427240EF96 Q26773907-93707443-455E-4158-9BBB-562FE86ABA46 Q31134354-418E6F70-1949-47DD-9A8A-49486D64369C Q33812500-08379A52-39A0-465D-BC9C-6D0285DF07F0 Q33898517-D5B293E1-6726-4335-BA17-2C98CFB275BA Q34034112-811D7D05-5B11-4C35-A007-223CB4EB470B Q34219271-1F247D05-88B2-4236-BB35-C0FF10CEA0A3 Q34677862-C5339E56-1107-41C7-AB71-8A3DCFFBBDD5 Q35100064-5B6A445A-E92E-4DA6-8AC3-EA6A81F008E7 Q35229461-47E66BDA-340C-4653-A495-E7B9EABF5F0F Q35434433-06C4ADDF-54EA-482B-8386-88E9479705FD Q35890623-37CF246A-A982-42BC-A180-3E5ED4B092B5 Q36109766-5FBCB3ED-64E8-4E28-8B31-4F9C6703768C Q36489321-C91964EF-19C7-4FAA-88DF-C84258B61CFC Q36709515-D42E1295-E8C0-4FCB-9CE3-5B3105597A04 Q36918276-3551F22B-A291-47A4-9FA6-FC68DEFC563C Q37057171-90DE2B3E-BEF0-4BF5-B0EB-4DF16CDBC13D Q37093018-534E75A2-03BC-4618-A855-5F90F5F4BBEF Q37190379-4C55DCFC-01C9-4A7F-AFC5-E699C3DCC19D Q37580471-9BF21CF8-14DA-46C8-969C-6912DCDAA412 Q37607675-F9DE42B4-FE14-4159-8F6D-03E8A29498DF Q37610963-26356F1A-C954-4CF9-BCD7-FCD5EA8B3F02 Q38935156-DF5E0E91-67F3-4E2C-8804-CCCF15FE4AA0 Q40228356-21174220-A9EE-4F38-B602-4128FF6DE82A Q50045875-DDF3E92E-BEFB-40DA-9E9B-5523A08AA414 Q52955581-D96803DA-8EF9-44C1-933A-018E67888A82 Q58618187-6A5675F1-934D-4CC9-83E0-E2447C41B542

P2860

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.

http://www.wikidata.org/entity/Q33903965

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.

@ast

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.

@en

type

label

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.

@ast

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.

@en

prefLabel

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.

@ast

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.

@en

P1433

Q33903965-14ED589F-79C2-44F2-81A8-DD203A6CE80E

P1476

Q33903965-4B8837D2-00E7-41D8-9D39-FFE6C5D35D83

P2093

Q33903965-147B0EA9-129F-45EB-9679-903FEB45EEB8

Q33903965-1A1BDB1B-3BC3-4B3F-A0D4-BF70A54C7592

Q33903965-8145F6E4-BDD8-4495-AFA3-EC0CDA687438

Q33903965-9B7881D4-5C68-49AC-9147-A33E91DA8227

Q33903965-A4DB1A2A-9B8E-468D-AC8C-CBEDDE1756ED

Q33903965-AD20EE7D-73DC-4C12-9B32-F624E405127C

Q33903965-C5B4D345-5D7D-4F93-9A1C-B2DE7042C607

P2860

Q33903965-002F5A63-FF9C-4021-A1EB-F714BA49CC5D

Q33903965-0187E299-6B91-4082-8F36-9E59E8933946

Q33903965-01A0F36E-2C6C-456D-AFAD-4FD29931DD5D

Q33903965-0335F5A9-E948-4955-A500-C4ABEBC97274

Q33903965-055EB0A3-808F-44E6-9C8D-D8ED6DDF08CB

Q33903965-094502DD-E285-494B-9186-23A4F308DE92

Q33903965-0AA3BC30-B482-4B97-965D-D5502BCEAF73

Q33903965-0C11EEF5-4D20-4816-99CF-2FB68F3104C1

Q33903965-0EAF43D1-1547-4004-BCA4-D7CE1E592F11

Q33903965-0F5120CC-0206-4B81-81DE-335AC3CDAA08

P304

Q33903965-09550627-B1DC-481C-B0E1-47BC0B103139

P31

Q33903965-EC42228F-BF0A-42A9-B5E7-362164E60B77

P407

Q33903965-927571A5-645F-46D5-9F87-3D5D086CA891

P478

Q33903965-8547ED60-4051-4017-B77F-2203F4F657DE

P577

Q33903965-57DBCE8D-043E-49FE-AE0A-B7180171A853

P698

Q33903965-7D7F305A-85AE-44D2-B296-29047349CC30

P932

Q33903965-651DACB4-9351-4E80-889B-DC5C2675EBAC

P1433

Clinical Medicine: Oncology

P1476

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.

@en

P2093

Dejan Maglic

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Fry

http://www.w3.org/2001/XMLSchema#string

Fumitake Kai

http://www.w3.org/2001/XMLSchema#string

Kazushi Inoue

http://www.w3.org/2001/XMLSchema#string

Pankaj Taneja

http://www.w3.org/2001/XMLSchema#string

Robert D Kendig

http://www.w3.org/2001/XMLSchema#string

Sinan Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins

Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers

AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor

Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Cyclin E and survival in patients with breast cancer.

Cyclin D1 in breast cancer pathogenesis.

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.

Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.

P304

15-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20567632

http://www.w3.org/2001/XMLSchema#string

P932

2883240

http://www.w3.org/2001/XMLSchema#string